EN
抗体药类似物
Research Grade Lesofavumab
All
TD-VK515056_1.jpg
TD-VK515056_2.jpg
  • CatalogTD-VK515056
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsRG6024,RG6024,MHAB5553A,RG70026,RO7045557,CAS:1807960-57-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Lesofavumab


Catalog No. TD-VK515056
Description Lesofavumab is a recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing Lesofavumab (RG6024), a monoclonal antibody, for the treatment of influenza B infections.
Species reactivity Influenza B virus
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target HA/Hemagglutinin
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P03461
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names RG6024,RG6024,MHAB5553A,RG70026,RO7045557,CAS:1807960-57-1
Background Lesofavumab (MHAB5553A) is a human IgG1κ anti-influenza B virus antibody.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK515056_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Lesofavumab.
TD-VK515056_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Lesofavumab.